<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 10.6: The Role of Testosterone in Female Sexual Health</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE theme for Sexual Health */
        .module-header {
            background: linear-gradient(135deg, #6d28d9 0%, #8b5cf6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #6d28d9;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #6d28d9;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #6d28d9;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #8b5cf6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #6d28d9;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #6d28d9;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #8b5cf6;
        }

        .term-item .term {
            font-weight: 700;
            color: #6d28d9;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #6d28d9;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e9d5ff 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Welcome/Intro Box */
        .welcome-box {
            background: linear-gradient(135deg, #f5f3ff 0%, #ede9fe 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #ddd6fe;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #6d28d9;
            font-weight: 600;
        }

        .welcome-box p {
            margin: 0;
            font-size: 17px;
            line-height: 1.8;
            color: #444;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box .alert-label {
            font-weight: 600;
            margin: 0 0 12px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .alert-box.warning {
            background: #fff8e6;
            border-left-color: #ff9800;
        }

        .alert-box.warning .alert-label {
            color: #e65100;
        }

        .alert-box.info {
            background: #e3f2fd;
            border-left-color: #2196f3;
        }

        .alert-box.info .alert-label {
            color: #1565c0;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #6d28d9 0%, #8b5cf6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #8b5cf6, #6d28d9);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #6d28d9 0%, #8b5cf6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Comparison Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        .data-table th {
            background: #f9fafb;
            padding: 16px;
            font-weight: 600;
            color: #6d28d9;
            border-bottom: 2px solid #e5e7eb;
        }

        .data-table td {
            padding: 16px;
            border-bottom: 1px solid #f3f4f6;
            color: #4b5563;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .check-understanding .box-label {
            font-weight: 600;
            color: #8B6914;
            margin: 0 0 8px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .question-number {
            position: absolute;
            top: -12px;
            left: 20px;
            background: #6d28d9;
            color: white;
            width: 28px;
            height: 28px;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-weight: 600;
            font-size: 13px;
        }

        .reveal-btn {
            background: #6d28d9;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #2e7d32;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #f0f8f0;
            border-radius: 8px;
            line-height: 1.6;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: linear-gradient(135deg, #f5f5f5 0%, #e8e8e8 100%);
            padding: 22px 25px;
            margin-top: 35px;
            border-radius: 8px;
            border: 1px solid #ddd;
        }

        .references-box {
            margin-top: 40px;
            padding-top: 25px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #333;
            margin-bottom: 15px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
            opacity: 0.9;
        }

        .lesson-footer .brand {
            color: #6d28d9;
            font-weight: 600;
            margin: 0;
            font-size: 15px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 10: Sexual Health and Intimacy</p>
            <h1 class="lesson-title">Lesson 10.6: The Role of Testosterone in Female Sexual Health</h1>
            <div class="lesson-meta">
                <span class="meta-item">32 min read</span>
                <span class="meta-item">Lesson 6 of 8</span>
            </div>
        </header>

        <!-- Table of Contents -->
        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The "Male Hormone" Myth</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Production & Age-Related Decline</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Understanding HSDD</a></li>
                <li><a href="#section4"><span class="section-num">4</span>The VITAL Connection</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Safety & Delivery Methods</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Practitioner Screening</a></li>
            </ul>
        </div>

        <!-- Learning Objectives -->
        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Explain the biological sources and physiological importance of testosterone in women.</li>
                <li>Identify the clinical criteria for Hypoactive Sexual Desire Disorder (HSDD).</li>
                <li>Analyze how testosterone supports the VITAL Methodâ„¢ principles of bone integrity and metabolic optimization.</li>
                <li>Differentiate between safe transdermal delivery methods and contraindicated oral routes.</li>
                <li>Understand the monitoring requirements and potential side effects of androgen therapy.</li>
            </ul>
        </div>

        <!-- Welcome Box -->
        <div class="welcome-box">
            <h3>Testosterone: The Unsung Hero of Female Vitality</h3>
            <p>While estrogen often takes center stage in menopause discussions, testosterone is actually the most abundant biologically active steroid hormone in a woman's body. It plays a critical role not just in libido, but in cognitive function, muscle maintenance, and bone density. As a Menopause Support Coach, understanding how to discuss androgen insufficiency can be the missing piece for clients who feel they have "lost their spark" despite traditional HRT.</p>
        </div>

        <!-- Key Terms -->
        <div class="key-terms-box">
            <p class="box-label">ðŸ”¬ Key Terms to Know</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">HSDD</p>
                    <p class="definition">Hypoactive Sexual Desire Disorder; characterized by a persistent lack of sexual interest that causes personal distress.</p>
                </div>
                <div class="term-item">
                    <p class="term">SHBG</p>
                    <p class="definition">Sex Hormone Binding Globulin; a protein that binds to testosterone, making it "unavailable" for use by the body's tissues.</p>
                </div>
                <div class="term-item">
                    <p class="term">Free Testosterone</p>
                    <p class="definition">The small percentage of testosterone not bound to proteins, which is biologically active and able to enter cells.</p>
                </div>
                <div class="term-item">
                    <p class="term">Androgen Insufficiency</p>
                    <p class="definition">A clinical state of low androgen levels accompanied by symptoms like low libido, fatigue, and reduced wellbeing.</p>
                </div>
            </div>
        </div>

        <h2 id="section1">The "Male Hormone" Myth</h2>
        <p>The common misconception that testosterone is strictly a "male hormone" has historically led to the under-diagnosis of androgen insufficiency in women. In reality, healthy young women produce approximately <span class="highlight">100 to 400 micrograms of testosterone per day</span>â€”roughly three to four times the amount of estrogen produced daily during the early follicular phase.</p>

        <p>Testosterone receptors are located throughout the female body, including the brain (hypothalamus and amygdala), bone, adipose tissue, and the cardiovascular system. Its primary role in sexual health involves <span class="highlight">central nervous system activation</span>; it modulates the "gas pedal" of sexual desire in the brain, while estrogen often handles the "lubrication" and physical comfort aspects.</p>

        <!-- Statistics Box -->
        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">3-4x</div>
                    <div class="stat-label">More T than Estrogen</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">50%</div>
                    <div class="stat-label">Loss by Age 45</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">32%</div>
                    <div class="stat-label">HSDD Prevalence</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">1/10th</div>
                    <div class="stat-label">Typical Female Dose</div>
                </div>
            </div>
        </div>

        <h2 id="section2">Production & Age-Related Decline</h2>
        <p>Unlike estrogen, which drops precipitously during the menopausal transition, testosterone levels in women begin a <span class="highlight">gradual decline starting in the late 20s or early 30s</span>. By the time a woman reaches natural menopause, she has typically lost about 50% of her peak testosterone levels.</p>

        <p>Production is divided into three primary sources:</p>
        <ul>
            <li><strong>Ovaries (25%):</strong> Direct secretion of testosterone.</li>
            <li><strong>Adrenal Glands (25%):</strong> Secretion of testosterone and its precursor, DHEA.</li>
            <li><strong>Peripheral Conversion (50%):</strong> Conversion of androstenedione (from ovaries/adrenals) into testosterone in the skin, fat cells, and liver.</li>
        </ul>

        <div class="alert-box warning">
            <p class="alert-label">Surgical Menopause Alert</p>
            <p>Women who undergo a bilateral oophorectomy (removal of both ovaries) experience an immediate and permanent <span class="highlight">50% drop in circulating testosterone</span>. These women often report much more severe sexual dysfunction and fatigue than those undergoing natural menopause.</p>
        </div>

        <h2 id="section3">Understanding HSDD</h2>
        <p>Hypoactive Sexual Desire Disorder (HSDD) is the most common form of female sexual dysfunction. It is defined not just by low desire, but by the <span class="highlight">distress</span> it causes the individual. If a woman has low desire but is unbothered by it, it is not clinically classified as HSDD.</p>

        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Symptom</th>
                        <th>Estrogen Deficiency</th>
                        <th>Testosterone Deficiency</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Vaginal Dryness</td>
                        <td>Primary Cause</td>
                        <td>Minimal Impact</td>
                    </tr>
                    <tr>
                        <td>Spontaneous Desire</td>
                        <td>Secondary Impact</td>
                        <td>Primary Cause</td>
                    </tr>
                    <tr>
                        <td>Arousal/Sensation</td>
                        <td>Moderate Impact</td>
                        <td>High Impact (Clitoral)</td>
                    </tr>
                    <tr>
                        <td>Orgasm Intensity</td>
                        <td>Low Impact</td>
                        <td>High Impact</td>
                    </tr>
                    <tr>
                        <td>Energy/Vitality</td>
                        <td>Related to Sleep</td>
                        <td>Direct Metabolic Link</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section4">The VITAL Connection</h2>
        <p>In our <strong>VITAL Methodâ„¢</strong>, testosterone plays a pivotal role in two specific pillars: <strong>Vascular & Bone Integrity (V)</strong> and <strong>Insulin & Metabolic Optimization (I)</strong>.</p>

        <div class="principle-card">
            <p class="principle-title">V: Vascular & Bone Integrity</p>
            <p class="principle-text">Testosterone is a potent bone-building hormone. It stimulates osteoblast (bone-forming cell) activity. Research indicates that low testosterone is a significant risk factor for postmenopausal osteoporosis, independent of estrogen levels.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">I: Insulin & Metabolic Optimization</p>
            <p class="principle-text">Testosterone is essential for maintaining lean muscle mass (sarcopenia prevention). Since muscle is the primary site for glucose disposal, adequate testosterone levels help maintain insulin sensitivity and prevent the "menopause middle" weight gain.</p>
        </div>

        <!-- Case Study -->
        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The Missing Piece</p>
                    <p style="color: white; font-size: 13px; margin: 0;">Restoring desire and drive</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah, 54</h4>
                        <p>Post-menopausal | On Estrogen/Progesterone HRT</p>
                    </div>
                </div>
                <p><strong>Presenting Symptoms:</strong> Sarah reported that while her hot flashes had stopped since starting HRT, she felt "flat." She described a total lack of sexual desire, brain fog, and an inability to maintain muscle despite strength training. Her relationship was strained due to her lack of intimacy.</p>
                <p><strong>Intervention:</strong> After a referral to a specialist, Sarah's blood work showed Free Testosterone in the lowest 5th percentile. She was prescribed a compounded transdermal testosterone cream (0.5mg/day).</p>
                <p><strong>Outcomes:</strong>
                <ul>
                    <li>Month 1: Improved energy and mental clarity.</li>
                    <li>Month 3: Return of spontaneous sexual thoughts and increased clitoral sensitivity.</li>
                    <li>Month 6: Significant improvement in muscle tone and a 40% increase in sexual satisfaction scores.</li>
                </ul>
                </p>
            </div>
        </div>

        <h2 id="section5">Safety & Delivery Methods</h2>
        <p>The 2019 Global Consensus Position Statement on the Use of Testosterone in Women concluded that testosterone therapy is effective for postmenopausal women with HSDD. However, the <span class="highlight">route of administration is critical</span>.</p>

        <p><strong>Oral Testosterone:</strong> Generally contraindicated. Oral intake passes through the liver, increasing SHBG (which lowers free testosterone) and negatively impacting cholesterol (lowering HDL, raising LDL).</p>

        <p><strong>Transdermal (Cream/Gel):</strong> The preferred method. It bypasses the liver and delivers a steady physiological dose. Practitioners must ensure the dose is for <em>women</em>, not men. A typical female dose is roughly 1/10th of a male dose.</p>

        <div class="alert-box info">
            <p class="alert-label">Side Effect Monitoring</p>
            <p>At physiological doses (restoring levels to a young woman's range), side effects are rare. However, coaches should help clients monitor for:
            <br>â€¢ Acne or oily skin
            <br>â€¢ Increased facial hair (hirsutism)
            <br>â€¢ Alopecia (hair thinning on head)
            <br>If these occur, the dose is likely too high (supraphysiological).</p>
        </div>

        <h2 id="section6">Practitioner Screening</h2>
        <p>As a Menopause Support Coach, you do not diagnose or prescribe. Your role is to <span class="highlight">identify candidates</span> who may benefit from a medical consultation. If a client presents with the following, a referral is warranted:</p>
        <ol class="content-list">
            <li>Persistent low libido that causes them distress (HSDD).</li>
            <li>Lack of response to standard Estrogen/Progesterone therapy regarding sexual function.</li>
            <li>Unexplained fatigue and loss of muscle mass despite proper nutrition and training.</li>
            <li>Feeling "emotionally blunted" or lacking motivation (the "anhedonia" of menopause).</li>
        </ol>

        <!-- Check Your Understanding -->
        <div class="check-understanding">
            <p class="box-label">Knowledge Check</p>
            <p class="box-subtitle">Test your understanding of female testosterone therapy.</p>

            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Why is the transdermal route preferred over oral testosterone for women?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Show Answer</button>
                <p class="answer-text">Oral testosterone undergoes "first-pass metabolism" in the liver, which increases SHBG (lowering active testosterone) and can negatively affect cholesterol levels. Transdermal delivery bypasses the liver and maintains a better safety profile.</p>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">What is the specific criteria required to move from "low desire" to a diagnosis of HSDD?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Show Answer</button>
                <p class="answer-text">The presence of "distress." Clinical HSDD requires that the lack of desire causes the woman personal or interpersonal distress.</p>
            </div>
        </div>

        <!-- Key Takeaways -->
        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Testosterone is a vital female hormone, produced by the ovaries and adrenals, declining by 50% by age 45.</li>
                <li>HSDD is the primary clinical indication for testosterone therapy in women.</li>
                <li>Testosterone supports the VITAL Methodâ„¢ by protecting bone density and maintaining metabolic muscle mass.</li>
                <li>Transdermal delivery is the gold standard for safety; oral testosterone should be avoided.</li>
                <li>Coaches play a key role in identifying HSDD and referring clients for androgen screening.</li>
            </ul>
        </div>

        <!-- References -->
        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Davis et al. (2019). "Global Consensus Position Statement on the Use of Testosterone in Women." <i>The Lancet Diabetes & Endocrinology</i>.</li>
                <li>Islam et al. (2019). "Testosterone therapy for reduced libido in postmenopausal women." <i>Journal of Clinical Endocrinology & Metabolism</i>.</li>
                <li>Wierman et al. (2014). "Androgen therapy in women: a clinical practice guideline." <i>Endocrine Society</i>.</li>
                <li>Shifren et al. (2000). "Transdermal Testosterone Treatment in Women with Impaired Sexual Function after Oophorectomy." <i>New England Journal of Medicine</i>.</li>
                <li>Zhu et al. (2022). "The effect of testosterone on bone mineral density in postmenopausal women: A systematic review." <i>Journal of Women's Health</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy Certified Menopause Support Coach</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. Professional Certification Content.</p>
        </footer>
    </div>
</body>

</html>